Oral vitamin C supplementation to patients with myeloid cancer on azacitidine treatment: Normalization of plasma vitamin C induces epigenetic changes

“We show for the first time that global 5hmC/5mC levels were significantly increased in mononuclear myeloid cells from patients receiving oral vitamin C compared to placebo “ https://t.co/gZgBg5Fag0

RT @SU2Cscience: For patients with myeloid cancers, restoring vitamin C levels to normal with oral supplements is possible + may improve th…

The simple use of oral vitamin C appears to correct low levels in the blood in patients with hematological / blood cancers such as AML, MDS, and CMML (who are also commonly deficient).... https://t.co/Vu0FFHkn5m

RT @cardeacl: Oral vitamin C supplementation to patients with myeloid cancer on azacitidine treatment: Normalization of plasma vitamin C in…